Germinal centre-like structures in Wegener's granuloma: The morphological basis for autoimmunity?

Rheumatology

Volumn 47, Issue 8, 2008, Pages 1111-1113

  Mueller, A ^a   Holl Ulrich, K ^a   Lamprecht, P ^a   Gross, W L ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MYELOBLASTIN; NEUTROPHIL CYTOPLASMIC ANTIBODY;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; DENDRITIC CELL; DISEASE MODEL; EDITORIAL; EPITHELIOID CELL; GIANT CELL; GRANULOMATOUS INFLAMMATION; HUMAN; IMMUNOCOMPETENT CELL; MORPHOLOGY; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PLASMA CELL; PRIORITY JOURNAL; T LYMPHOCYTE; VASCULITIS; WEGENER GRANULOMATOSIS;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; AUTOIMMUNITY; GERMINAL CENTER; HUMANS; MYELOBLASTIN; WEGENER GRANULOMATOSIS;

EID: 47849090521     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ken202     Document Type: Editorial

References (49)

1. Jennette JC, Falk RJ. Small vessel vasculitis. N Engl J Med 1997;337:1512-23.
2. Voswinkel J, Mueller A, Kraemer JA et al. B lymphocyte maturation in Wegener's granulomatosis: A comparative analysis of VH genes from endonasal lesions. Ann Rheum Dis 2006;65:859-64.
3. Krämer JA, Müller A, Herlyn K et al. B lymphocyte differentiation in granulomatous tissues of the lung and the nasal mucosa in Wegener's granulomatosis. Origin of anti-neutrophil cytoplasmic antibody formation? Z Rheumatol 2007;66:421-9.
4. Csernok E, Ai MX, Gross WL et al. Wegener autoantigen induces maturation of dendritic cells and licences them for Th1 priming via the protease-activated receptor-2 pathway. Blood 2006;107:4440-8.
5. Kantari C, Pederzoli-Ribeil M, Amir-Moazami O. Proteinase 3, the Wegener autoantigen, is externalized during neutrophil apoptosis: Evidence for a functional association with phopsholipid scramblase 1 and interference with macrophage phagocytosis. Blood 2007;110:4086-95.
6. + effector memory T cells and expression of NKG2D ligand MIC in granulomatous lesions in Wegener's granulomatosis. Clin Immunol 2008;127:144-50.
7. Holl-Ulrich K, Both M, Gross WL, Gottschlich S, Aries P, Lamprecht P. Saddle nose deformity caused by destructive granulomatous inflammation in Wegener's granulomatosis. Arthritis Rheum 2008;58:834.
8. Lamprecht P, Gross WL. Current knowledge on cellular interactions in the WG granuloma. Clin Exp Rheumatol 2007;25:949-51.
9. Lamprecht P, Gross WL, Kabelltz D. T cell alterations and lymphoid neogenesis favoring autoimmunity in Wegener's granulomatosis. Arthritis Rheum 2007;56:1725-7.
10. Gross WL, Lüdemann G, Kiefer G, Lehmann H. Anticytoplasmic antibodies in Wegener's granulomatosis. Lancet 1986;1:806.
11. Hoffman GS, Kerr GS, Leavitt RY et al. Wagener's granulomatosis: an analysis of 158 patients. Ann Intern Med 1992;116:488-98.
12. Reinhold-Keller E, Beuge N, Latza U et al. An interdisciplinary approach to the care of patients with Wegener's granulomatosis. Arthritis Rheum 2000;43:1021-32.
13. Reinhold-Keller E, Lamprecht P, Feller AC, Gross WL. Polyarthritis following interferon alpha treatment in a patient with localized Wegener's granulomatosis. Clin Exp Rheumatol 2001;19:227-8.
14. Holl-Ulrich K, Reinhold-Keller E, Müller A, Feller AC. Pathology of vasculitis: Differential diagnosis and selected disorders. Verh Dtsch Ges Path 2002;86:83-90.
15. Fienberg R. The protracted superficial phenomenon in pathergic (Wegener's) granulomatosis. Hum Pathol 1981;12:458-67.
16. Matsubara O, Yoshimura N, Doi Y, Tamura A, Mark EJ. Nasal biopsies in the early diagnosis of Wegener's (pathergic) granulomatosis. Virchows Archiv 1996; 428:13-19.
17. Drayton DL, Liao S, Mounzer RH, Ruddle NH. Lymphoid organ development: from ontogeny to neogenesis. Nat Immunol 2006;7:344-53.
18. Salomonsson S, Jonsson MV, Skarstein K et al. Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjögren's syndrome. Arthritis Rheum 2003;48:3187-201.
19. Klimiuk PA. Goronzy JJ, Björnsson J, Beckenbaugh RD, Weyand CM. Tissue cytokine patterns distinguish variants of rheumatoid synovitis. Am J Path 1997;151: 1311-9.
20. Highton J, Hung N, Hessian P, Wilsher M. Pulmonary rheumatoid nodules demonstrating features usually associated with rheumatoid synovial membrane. Rheumatology 2007;46:811-4.
21. Weyand CM, Seyler TM, Goronzy JJ. B cells in rheumatoid synovitis. Arthritis Res 2005;7:9-12.
22. Raulet DH. Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol 2003;3:781-90.
23. Zinkemagel RM. Antiinfection immunity and autoimmunity. Ann NY Acad Sci 2002;958:3-6.
24. Jagiello P, Gross WL, Epplen JT. Complex genetics of Wegener's granulomatosis. Autoimmun Rev 2005;4:42-7.
25. Szyld P, Jagiello P, Csernok E, Gross WL, Epplen JT. On the Wegener's granulomatosis associated region on the chromosome 6p21.3. BMC Med Genet 2006;7:21.
26. Pops ER, Cohen Tervaert JW. The relation between Staphylococcus aureus and Wegener's granulomatosis: Current knowledge and future directions. Int Med 2003;42:771-80.
27. Pope ER, Stegeman CA, Abdulahad WH et al. Staphylococcal toxic-shock-syndrome-toxin-1 as a risk factor for disease relapse in Wegener's granulomatosis. Rheumatology 2007;46:1029-33.
28. Witko-Sarsat V, Lesavre P, Lopez S et al. A large subset of neutrophils expressing membrane proteinase 3 is a risk factor for vasculitis and rheumatoid arthritis. J Am Soc Nephrol 1999;10:1224-33.
29. Csernok E, Ernst M, Schmitt W, Bainton DF, Gross WL. Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo. Clin Exp Immunol 1994;95:244-50.
30. Campbell EJ, Campbell MA, Owen CA. Bioactive proteinase 3 on the cell surface of human neutrophils: Quantification, catalytic activity and susceptibility to inhibition. J Immunol 2000;165:3366-74.
31. Gencik M, Mailer S, Borgmann S, Fricke H. Proteinase 3 gene polymorphisms and Wegener's granulomatosis. Kidney Int 2000;58:2473-7.
32. Braun MG, Csernok E, Gross WL, Müller-Hermelink HK. Proteinase 3, the target antigen of anticytoplasmic antibodies circulating in Wegener's granulomatosis. Am J Path 1991;139:831-8.
33. Brockmann H, Schwarting A, Kriegsmann J et al. Proteinase-3 as the major autoantigen of c-ANCA is strongly expressed in lung tissue of patients with Wegener's granulomatosis. Arthritis Res 2002;4:220-5.
34. Wiedow, O, Meyer-Hoffert U. Neutrophil serine proteases: Potential key regulators of cell signalling during inflammation. J Intem Med 2005;257:319-28.
35. Plotz PH. The autoantibody repertoire: Searching for order. Nat Reviews Immunol 2003;3:73-8.
36. Mackiewicz Z, Rimkeviclus A, Petersen J et al. Macrophages overloaded with tissue debris in Wegener's granulomatosis. Ann Rheum Dis 2006;64:1229-32.
37. Müller A, Voswinkel J, Gottschlich S, Csernok E. Human proteinase 3 and its binding molecules. Ann NY Acad Sci 2007;1109:84-92.
38. Coulomb-L'Hermine A, Capron F, Zou W et al. Expression of the chemokine RANTES in pulmonary Wegener's granulomatosis. Hum Pathol 2001;32:320-6.
39. Jagiello P, Aries P, Arning L et al. The PTPN22 620W allele is a risk factor for Wegener's granulomatosis. Arthritis Rheum 2005;52:4039-43.
40. Csernok E, Trabandt A, Müller A et al. Cytokine profiles in Wegener's granulomatosi. Arthritis Rheum 1999;42:742-50.
41. Müller A, Trabandt A, Glöckner-Hofmann K et al. Localized Wegener's granulomatosis: Predominance of CD26 and IFNγ expression. J Path 2000;192:113-20.
42. Lamprecht P, Brühl H, Erdmann A et al. Differences in CCR5 expression on peripheral blood CD4+CD28- T cells and in granulomatous lesions between localized and generalized Wegener's granulomatosis. Clin Immunol 2003;108:1-7.
43. Balding CEJ, Howie AJ, Drake-Lee AB, Savage COS. Th2 dominance in nasal mucosa in patients with Wegener's granulomatosis. Clin Exp Immunol 2001; 125:3329.
44. Komocsi A, Lamprecht P, Csemok E et al. Peripheral blood and granuloma CD4+CD28- T cells are a major source of interferon and tumor necrosis factor in Wegener's granulomatosis. Am J Path 2002;160:1717-24.
45. Lamprecht P, Moosig F, Csernok E et al. CD28 negative T cells are enriched in granulomatous lesions of the respiratory tract in Wegener's granulomatosis. Thorax 2001;56:751-7.
46. Heckmann M, Holle JU, Arning L et al. The Wegener's granulomatosis quantitative trait locus on chromosome 6p21.3 as characterized by tag SNP genotyping. Ann Rheum Dis. Advance Access published October 29, 2007, doi:10.1136/ard.2007.077693.
47. + T cells. J Immunol 2006;177: 3874-83.
48. H-17 cells in the circle of immunity and autoimmunity. Nat Immunol 2007;8:345-50.
49. Müller A, Lamprecht P. Interleukin-17 in chronic inflammatory and autoimmune diseases: Rheumatoid arthritis, Crohn's disease and Wegener's granulomatosis. Z Rheumatol 2008;67:72-4.